Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Atlas Arteria (ALX.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2022-04-086.476.58Neutral
2022-04-206.786.53Neutral
2022-06-088.25-No Rating
2022-09-017.967.15Neutral
2022-09-137.81-No Rating
2022-12-196.876.75Neutral
2023-01-256.776.65Neutral
2023-02-276.776.55Neutral
2023-07-246.266.65Neutral
2023-09-285.616.05Neutral
2023-10-215.375.70Neutral
2024-04-245.385.60Neutral
2024-07-235.145.50Neutral
2024-08-305.105.35Neutral
2025-02-285.065.20Neutral
2025-04-234.935.15Neutral

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.